While others wait for change to come,
we choose to leap.
Because disease doesn’t wait, neither do we. And so together, with our partners and the patients we serve at our side, we’re marching ahead. Turning one-size-fits-all treatment into personalized medicine for all. C’mon. Let’s leap.
QUANTUM LEAP HEALTHCARE COLLABORATIVE
A leap in treatment options
and innovations ready to explore.
A leap that’s saving lives.
Dr. Laura Esserman alongside Quantum is challenging the status quo with the Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: Ductal Carcinoma In Situ (RECAST DCIS) study. This Phase 2 platform study seeks to shift the paradigm of standard treatment of care and perception of DCIS as an invasive cancer and instead aims at preventing the progression of DCIS to breast cancer.
Find the latest leaps happening near you.
Our innovative cancer trials are all happening over making positive breakthroughs every day in the advancement of patient outcomes. Use our helpful map to find the latest ones near you.
A leap in research happens with world-class partners.
Together with our incredible partners in the pharma and healthcare world,
we’re making bigger leaps than ever before to advance personalized medicine for all.
